Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carlsbad, California
- Most recent report
- 8-K, filed Sep 9, 2026
- Incorporated
- Delaware
- Filings on record
- 413 filings
- On EDGAR
- CIK 1863127
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 20
News 8 of 45
Prospectuses and Registrations 8 of 10
- 424B5 Prospectus supplement for an offering Aug 4, 2026
- S-3 Shelf registration statement May 8, 2025
- S-8 Registration statement for an employee plan Mar 19, 2024
- S-3 Shelf registration statement Mar 19, 2024
- S-3 Shelf registration statement Oct 3, 2022
- S-8 Registration statement for an employee plan Sep 15, 2021
- 424B4 Final prospectus for an offering Sep 15, 2021
- S-1/A Registration statement for an offering, amended Sep 14, 2021
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- DEFA14A Extra proxy material Apr 18, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2025
- DEFA14A Extra proxy material May 7, 2024
- DEFA14A Extra proxy material Apr 18, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2024
- PRE 14A Preliminary proxy statement Apr 5, 2024
Ownership 8 of 299
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 30, 2026
- 144 Notice of a proposed sale of restricted stock Jun 26, 2026
- 4 Insider reported a trade Jun 1, 2026
- 4 Insider reported a trade Jun 1, 2026
- 4 Insider reported a trade Jun 1, 2026
- 4 Insider reported a trade Jun 1, 2026
Other 8 of 27
- ARS Annual report sent to shareholders Apr 17, 2026
- EFFECT Notice that a registration became effective May 16, 2025
- CORRESP Reply to SEC staff May 14, 2025
- UPLOAD Comment letter from SEC staff May 12, 2025
- ARS Annual report sent to shareholders Apr 18, 2025
- EFFECT Notice that a registration became effective Apr 22, 2024
- CORRESP Reply to SEC staff Apr 18, 2024
- ARS Annual report sent to shareholders Apr 18, 2024
Everything here comes from Tyra Biosciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.